Literature DB >> 10602461

Activators and target genes of Rel/NF-kappaB transcription factors.

H L Pahl1.   

Abstract

The vertebrate transcription factor NF-kappaB is induced by over 150 different stimuli. Active NF-kappaB, in turn, participates in the control of transcription of over 150 target genes. Because a large variety of bacteria and viruses activate NF-kappaB and because the transcription factor regulates the expression of inflammatory cytokines, chemokines, immunoreceptors, and cell adhesion molecules, NF-kappaB has often been termed a 'central mediator of the human immune response'. This article contains a complete listing of all NF-kappaB inducers and target genes described to date. The collected data argue that NF-kappaB functions more generally as a central regulator of stress responses. In addition, NF-kappaB activation blocks apoptosis in several cell types. Coupling stress responsiveness and anti-apoptotic pathways through the use of a common transcription factor may result in increased cell survival following stress insults.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602461     DOI: 10.1038/sj.onc.1203239

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  1147 in total

1.  Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.

Authors:  M Nees; J M Geoghegan; T Hyman; S Frank; L Miller; C D Woodworth
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Stereotyped and specific gene expression programs in human innate immune responses to bacteria.

Authors:  Jennifer C Boldrick; Ash A Alizadeh; Maximilian Diehn; Sandrine Dudoit; Chih Long Liu; Christopher E Belcher; David Botstein; Louis M Staudt; Patrick O Brown; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 3.  Innate immunity and inflammation: a transcriptional paradigm.

Authors:  J Hawiger
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice.

Authors:  Mohammed Kashani-Sabet; Yong Liu; Sylvia Fong; Pierre-Yves Desprez; Shuqing Liu; Guanghuan Tu; Mehdi Nosrati; Chakkrapong Handumrongkul; Denny Liggitt; Ann D Thor; Robert J Debs
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 5.  New insights into the role of nuclear factor-kappaB in cell growth regulation.

Authors:  F Chen; V Castranova; X Shi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 6.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 7.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

Authors:  Y Yamamoto; R B Gaynor
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 8.  Role of nuclear factor kappaB in synovial inflammation.

Authors:  Ulf Müller-Ladner; Renate E Gay; Steffen Gay
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

9.  Mutational analysis of the v-Rel dimerization interface reveals a critical role for v-Rel homodimers in transformation.

Authors:  Andrew S Liss; Henry R Bose
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 10.  NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer.

Authors:  Hana Algül; Guido Adler; Roland M Schmid
Journal:  Int J Gastrointest Cancer       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.